Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Head and Neck Cancers, An Issue of PET Clinics
- 1st Edition, Volume 17-2 - March 31, 2022
- Editor: Rathan M. Subramaniam
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 4 9 3 8 - 8
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 4 9 3 9 - 5
In this issue of PET Clinics, guest editor Dr. Rathan M. Subramaniam brings his considerable expertise to the topic of Head and Neck Cancers. Top experts in the field provide im… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of PET Clinics, guest editor Dr. Rathan M. Subramaniam brings his considerable expertise to the topic of Head and Neck Cancers. Top experts in the field provide important updates on planning, treatment, and individual head and neck cancers, with articles such as PET/CT: laryngeal and hypopharyngeal cancers; PET/CT: thyroid cancers; PET/CT: oral cavity and oropharyngeal cancers; and more.
-
Contains 10 relevant, practice-oriented topics including PET/CT: post-therapy follow-up in head and neck cancer; PET/CT: therapy response assessment in head and neck cancer; PET/CT: radiation therapy planning in head and neck cancer; PET/CT: nasopharyngeal cancers; and more.
-
Provides in-depth clinical reviews on head and neck cancers, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- CME Accreditation Page
- Preface
- Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma
- Key points
- Background
- Patient perspective of positron emission tomography scans
- Current standards of care in head and neck cancer management
- Pathology and immune landscape of head and neck cancer
- Typical use fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography imaging in head and neck cancer
- Novel approaches for immune landscape
- Future directions and considerations
- The evolving utilization of biomarkers in head and neck squamous cell carcinoma
- Summary
- Funding
- Clinics care points
- PET Imaging of Oral Cavity and Oropharyngeal Cancers
- Key points
- Introduction
- Staging oral cavity and oropharyngeal squamous cell carcinoma
- Imaging findings
- Primary tumor staging
- Staging cervical nodal metastases
- Staging distant disease and detection of a second primary malignancy
- Role in treatment planning
- Treatment response assessment and prognosis
- Detection of occult primary
- PET/MR imaging in oral cavity and oropharyngeal cancers
- Summary
- Clinics care points
- PET/Computed Tomography: Laryngeal and Hypopharyngeal Cancers
- Key points
- Introduction
- Laryngeal anatomy
- Hypopharyngeal anatomy
- Staging of laryngeal and hypopharyngeal tumors
- 18F FDG-PET/computed tomography evaluation of laryngeal and hypopharyngeal tumors
- Role of 18F FDG-PET/computed tomography in staging
- Role of 18F FDG-PET/computed tomography in prognostication
- Role of 18F FDG-PET/computed tomography in treatment planning
- Role of 18F FDG-PET/computed tomography in posttreatment response assessment
- Summary
- Clinics care points
- 18F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors
- Key points
- Introduction
- Clinical presentation and evaluation
- Relevant anatomy
- Role of PET/computed tomography in head and neck salivary gland tumors
- Special considerations
- Non–18F-fluorodeoxyglucose PET Radiotracers
- Pitfalls
- Summary
- Clinics Care Points
- Positron Emission Tomography/Computed Tomography in Thyroid Cancer
- Key points
- Introduction
- Mechanism of 18F-fluorodeoxyglucose uptake in thyroid cancer
- Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography
- Malignancy risk prediction of thyroid nodules with indeterminate cytology or suspicious neck ultrasonography
- Initial diagnosis in differentiated thyroid cancer
- Suspicious recurrence in differentiated thyroid cancer
- Prognostic role in differentiated thyroid cancer
- 68Ga-DOTA-SSTR analog positron emission tomography/computed tomography
- 68Ga-DOTA-RGD2 positron emission tomography/computed tomography in radioiodine refractory differentiated thyroid cancer
- Real-time USG-fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography fusion imaging
- 124I-PET PET/CT
- Fluorodeoxyglucose-positron emission tomography/computed tomography in Hürthle cell thyroid carcinoma
- Fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography in poorly differentiated thyroid cancer
- Fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography in anaplastic thyroid cancer
- Positron emission tomography/computed tomography in medullary thyroid cancer
- Positron emission tomography/computed tomography in thyroid lymphoma
- Nonstandard positron emission tomography/computed tomography in thyroid malignancy
- Summary
- Clinics care points
- PET/CT: Nasopharyngeal Cancers
- Key points
- Introduction
- Clinical presentation
- Normal anatomy of nasopharynx region
- Imaging technique
- Imaging findings/pathology
- Clinical applications and diagnostic criteria
- Differential diagnosis
- Advanced techniques
- Case study presentation
- Conclusion/summary
- Clinics care points
- PET/CT: Radiation Therapy Planning in Head and Neck Cancer
- Key points
- Introduction
- Modern radiotherapy
- Radiotherapy treatment planning
- FDG-positron emission tomography/computed tomography in primary tumor delineation
- FDG-positron emission tomography/computed tomography in lymph node delineation
- FDG-positron emission tomography/computed tomography-guided dose modification and response-adapted adaptive radiotherapy
- FDG-positron emission tomography/computed tomography-guided dose de-escalation
- Alternative tracers
- Positron emission tomography/computed tomography -guided radiotherapy
- Summary
- Clinics care points
- 2-Deoxy-2-[18F] Fluoro-d-Glucose PET/Computed Tomography: Therapy Response Assessment in Head and Neck Cancer
- Key points
- Introduction
- Expected posttreatment imaging findings and interpretive pitfalls
- Therapy response assessment: 2-deoxy-2-[18F] fluoro-d-glucose-PET–based response criteria
- Prognostic value of 2-deoxy-2-[18F] fluoro-d-glucose-PET–based metabolic parameters
- Immunotherapy response assessment in head and neck cancer
- Surveillance strategies in head and neck cancer
- Summary
- Clinics care points
- Disclosure
- PET/Computed Tomography: Post-therapy Follow-up in Head and Neck Cancer
- Key points
- Introduction
- Overview of post-therapy follow-up
- National Comprehensive Cancer Network guidelines for post-therapy imaging
- Routine post-therapy PET/computed tomography and timing in asymptomatic patients
- Post-therapy follow-up in human papillomavirus–related cancers
- Liquid biopsy in post-therapy follow-up
- Immunotherapy for head and neck cancers
- Summary
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 17-2
- Published: March 31, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323849388
- eBook ISBN: 9780323849395
RS
Rathan M. Subramaniam
Affiliations and expertise
Associate Professor of Radiology, Russell H Morgan Department of Radiology and Radiologic Sciences, John Hopkins Medical Institutions